Metraipolis › archive › dc_b5ea71046f99

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers — Europe PMC PMID:41705834

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41705834
DOI
10.1128/aac.01315-25
License (as archived)
solo-consultazione
Archived
2026-11-05T16:42:31.605Z
SHA-256 of the archived text
fb87b6bd5a4211f3a75cfb656daa44a95395ae9e6bfad3fbefe7fe466610e8e8
Stable URL of this page
https://metraipolis.com/documento/dc_b5ea71046f99

How to cite

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers — Europe PMC PMID:41705834 — Europe PMC (en), https://europepmc.org/article/MED/41705834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ea71046f99 (Metraipolis archive dc_b5ea71046f99, sha256 fb87b6bd5a4211f3a75cfb656daa44a95395ae9e6bfad3fbefe7fe466610e8e8)
BibTeX
@misc{dcb5ea71046f99,
  title = {Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers — Europe PMC PMID:41705834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41705834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ea71046f99; sha256 fb87b6bd5a4211f3a75cfb656daa44a95395ae9e6bfad3fbefe7fe466610e8e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41705834. Agents can read the archived copy with the MCP tool read_document.